|
Demographic details, rheumatoid arthritis characteristics, and laboratory values of 40 rheumatoid arthritis patients at first presentation |
|
| Demographic detail |
Value |
|
|
|
| Male:female |
13:27 |
| Mean age (years) |
53 (22–78) |
| Male mean age (years) |
58 (37–78) |
| Female mean age (years) |
51 (22–72) |
| Body mass index (kg/m2) |
28 (17–45) |
| Rheumatoid arthritis characteristics |
|
| Disease duration (months) |
7 (1.0–12) |
| Tender joint count (out of 53) |
19 (14) |
| Swollen joint count (out of 44) |
16 (10) |
| Patient's assessment of fatigue (visual analogue scale, maximum 100) |
38 (28) |
| Health assessment questionnaire score (maximum disability 24) |
4.4 (4.5) |
| Physician's global assessment of disease activity (maximum 100) |
41 (26) |
| Joint pain (visual analogue scale, maximum 100) |
50 (31) |
| Morning stiffness duration (min) |
195 (358) |
| Rheumatoid factor level |
228 (302) |
| Disease activity score (DAS 4v) |
4.39 (1.6) |
| Rheumatoid factor positive (n (%)) |
30 (75%) |
| Laboratory values |
|
| Erythrocyte sedimentation rate (mm/hour) |
36.5 (24) |
| C-reactive protein (mg/l, normal <6) |
25.5 (23) |
| Haemoglobin (g/l) |
131 (15) |
| Cholesterol (mmol/l) |
5.0 (1.0) |
| Triglyceride (mmol/l) |
1.4 (0.9) |
| High-density lipoprotein level (mmol/l) |
1.5 (0.4) |
| Total high-density lipoprotein/cholesterol ratio (mmol/l) |
3.6 (1.2) |
| Low-density lipoprotein cholesterol (mmol) |
2.8 (0.7) |
| Antinuclear antibody titre >1:160 (n (%)) |
28 (70%) |
|
Data presented as mean (range) or mean (standard deviation), unless indicated otherwise. | |
Hannawi et al. Arthritis Research & Therapy 2007 9:R116 doi:10.1186/ar2323 |
|